Braun Bostich & Associates Inc. Edesa Biotech, Inc. Transaction History

Braun Bostich & Associates Inc.

  • $140 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$4.25 - $8.14 $13,281 - $25,437
-3,125 Closed
0 $0
Q1 2020

May 11, 2020
BUY
$1.64 - $4.09 $5,125 - $12,781
3,125 New
3,125 $7,000

About Edesa Biotech, Inc.

EDSA Quotes by TradingView
  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $38.2M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track Braun Bostich & Associates Inc. Portfolio

Follow Braun Bostich & Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Bostich & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Braun Bostich & Associates Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email